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Summary: Computer tomography (CT) imaging plays an important role in cancer detection and quantitative assessment 
in clinical trials. High-resolution imaging studies on large cohorts of patients generate vast data sets, which are infeasible 
to analyze through manual interpretation.
In this article we describe a comprehensive architecture for computer-aided detection (CAD) and surveillance on lung 
nodules in CT images. Central to this architecture are the analytic components: an automated nodule detection system, 
nodule tracking capabilities and volume measurement, which are integrated within a data management system that includes 
mechanisms for receiving and archiving images, a database for storing quantitative nodule measurements and visualization, 
and reporting tools.
We describe two studies to evaluate CAD technology within this architecture, and the potential application in large clinical 
trials. The fi rst study involves performance assessment of an automated nodule detection system and its ability to increase 
radiologist sensitivity when used to provide a second opinion. The second study investigates nodule volume measurements 
on CT made using a semi-automated technique and shows that volumetric analysis yields signifi cantly different tumor 
response classifi cations than a 2D diameter approach. These studies demonstrate the potential of automated CAD tools to 
assist in quantitative image analysis for clinical trials.
Keywords: “Computer-Aided Diagnosis”, “Lung Nodules”, “CT”.
1. Introduction
Computer tomography (CT) imaging plays an important role in cancer detection, diagnosis and in 
quantitative assessment in clinical trials. CT data sets contain a large number of images per patient; a 
typical thin-section thoracic CT scan contains approximately 400 cross-sectional images with 1 mm 
spacing. A clinical trial usually involves large cohorts of patients, each patient potentially undergoing 
multiple scans over the trial’s course. Faced with this data overload, computer-assisted tools are being 
developed to detect and quantitate nodules in CT, and show great potential as an aid in image interpre-
tation.
There has been substantial research into the development of computer-aided detection (CAD) systems 
that can locate lung nodules and measure their size (1, 2, 3, 4, 5). However, there has been less emphasis 
on the infrastructure required to integrate these into a clinical trials setting, and enable data mining on 
derived image measures in large cohorts of patients. CAD systems are being developed, and their impact 
on reader performance evaluated, though not routinely used in clinical practice or large clinical trials, 
partly because they are not integrated within a data management infrastructure needed for a trial. 
Commercially available Picture Archiving and Communication Systems (PACS) focus on storage of 
image data and are not well suited for effi cient storage and mining of CAD or quantitative data.
In this article we describe a comprehensive architecture for CAD and surveillance on lung nodules 
in CT images. Central to this architecture are the analytic components: an automated nodule detection 
system, nodule tracking capabilities and volume measurement, and their integration within a data 
management system that includes mechanisms for receiving and archiving images, a database for storing 
quantitative nodule measurements and visualization, and reporting tools.
We will describe two studies to evaluate CAD technology within this architecture, and the potential 
application in large clinical trials. The fi rst study involves performance assessment of an automated nodule 
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detection system and its impact on a radiologist’s 
sensitivity (6). The second study investigates nodule 
volume measurements on CT (7). These studies 
show the potential of CAD tools to assist in quan-
titative image analysis for clinical trials.
2. Methods
2.1. Data model
We have developed a generic data and process 
model for quantitative image analysis within a 
centralized radiology core facility (8). Here we 
outline the model and focus on the aspects relevant 
to lung cancer imaging and assessment. The data 
model supports image data being collected within 
multi-center clinical trials and also allows multiple 
clinical trials to be stored and organized within a 
single database. This capability offers the potential 
for data mining across trials, effectively pooling 
cohorts of subjects.
Images are received from participating sites in 
Digital Imaging and Communications in Medicine 
(DICOM) format (9), transferred in encrypted form 
(10) to a secure DICOM receiver, and imported 
into our data server. During the importation, 
“header information,” including subject identifi ers 
and CT image acquisition parameters (slice thick-
ness, tube current, etc.), is extracted from the 
images. These fi elds are represented in the data 
model using the DICOM hierarchy of patient, 
imaging study, imaging series and image 
(Figure 1). Prior to transfer, patient name and other 
identifi ers are replaced in the imager header with 
a study identifi er, thus anonymizing the patient 
within the database. The image data is too large to 
be stored directly in the database (approximately 
50 MB for a single CT series of 100 images), so 
the database stores a path to the image fi les on the 
server.
Following import, image data can be analyzed 
using the Quantitative Imaging Workstation 
(QIWS) developed at UCLA. This workstation has 
a variety of automated and semi-automated CAD 
and measurement tools, described in Section 2.2. 
The quantitative output from these tools includes 
nodule image coordinates and boundaries, 
volumes, and attenuation measures. As shown in 
Figure 1, the data model includes tables storing 
this quantitative information linked to the image 
series table. Quantitative measurements are there-
fore associated with the corresponding CT scan, 
and can be related back to the subject through the 
DICOM hierarchy.
To support multiple clinical trials within the 
architecture, an Experiment table is included within 
the data model; an entry within the table corre-
sponds to a clinical trial. As shown in Figure 1, a 
row in the Image_Series can be associated with a 
row in the Experiment table, allowing subjects and 
quantitative measurements to be linked with one 
or more clinical trials. This is necessary to perform 
database queries relating to a specifi c trial and also 
for constructing patient worklists in QIWS for 
users working on multiple trials.
The data model has been implemented in Post-
greSQL: an open-source database (11). This 
currently includes images and derived quantitative 
data, but could be extended to include other diag-
nostic tests, e.g. pathology results.
2.2. Computer-aided analysis 
techniques
CAD techniques for lung nodules are typically 
automated systems used as a second reader. This 
means that a radiologist reviews the CT exams 
using standard practices looking for nodules. 
Subsequently, they can activate the automated 
system, which highlights nodules it has detected. 
The radiologist then has the option of accepting or 
rejecting additional CAD fi ndings. Here, CAD 
serves as a double checker for nodule detection.
The details of our CAD system have been 
described previously, but we provide an outline here. 
Nodules are typically more radio-dense than the 
surrounding lung parenchyma, thus having a higher 
X-ray attenuation (appearing brighter in a CT image 
against the dark background of the lung [Figure 2a]). 
Attenuation thresholding and 3D region-growing 
techniques are applied to create regions-of-interest 
(ROIs) in the image, which correspond to contiguous 
sets of voxels that have an X-ray attenuation above 
a defi ned threshold. As shown in Figure 2b, this 
generates many ROIs, mostly from parenchymal 
blood vessels and airway walls that have a similar 
attenuation to nodules. The challenge for a detection 
system is therefore to discriminate nodules from the 
bronchovascular anatomy—a challenge shared with 
visual detection.
The CAD system uses pattern classifi cation tech-
niques to discriminate between nodules and vessels. 
From each ROI the system computes quantitative 
features that characterize the ROI. Primary features 
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used in this task include ROI volume and shape. For 
an ROI consisting of a set of voxels, S, the volume 
and shape features are computed as follows:
 
Volume x voxel size p y
voxel size p z voxel size p
p S
=
∈
∑ _ _ ( )*
_ _ ( )* _ _ ( )
 
where x_voxel_size(p) is the size of the voxel, p, 
in the x-direction, with similar defi nitions in the 
y- and z-directions.
 Sphericity v
r
=100 3
4 3
*
π
 
where, r = 0.5 * [maximum dimension (x, y or z) 
of object’s bounding box], and v = volume of the 
object.
A perfectly spherical object will have a maximum 
sphericity feature value of 100. The more elongated 
the object, the lower the sphericity value.
The pattern classifi er contains a model of the 
expected appearance of nodules and vessels in 
terms of these features. The details are provided in 
(4,12), but the model refl ects that vessels are long, 
thin tubular structures in 3D and thus have a low 
sphericity value, whereas nodules have a higher 
sphericity value. This is illustrated in Figure 3 
showing a 3D rendering of a nodule and adjacent 
vessels. The system uses fuzzy logic to compute 
a confi dence score indicating whether a given ROI 
has features consistent with a nodule. ROIs with 
high confi dence for a nodule are presented to the 
user as shown in Figure 2c. The output of the 
CAD system is written to a row in the Segmenta-
tion_Results table. The row is associated with 
rows in the Image_Series and Segmentation_
Model tables to indicate the image data set and 
classifi cation model from which the CAD results 
were derived.
As part of clinical trials, diameter and/or volume 
measurements are required to assess nodule size 
following detection. To perform these measure-
ments, nodule boundaries must be identifi ed on 
each CT image slice, also known as segmentation. 
Marking (ROI)
DICOM Hierarchy
Image_Study
Image_Series Image
Patient
Experiment
Marking_Reviewer
Measurements
ROIs and Quantitative OutputCAD System
Segmentation_Results
Segmentation_Model
Parent-Child
Association
Legend
Figure 1. Overview of data model for image, CAD and quantitative data in a clinical trials setting.
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Lung nodules can have irregular and/or poorly 
defi ned margins. Therefore, the architecture also 
includes semi-automated tools for performing 
a more accurate definition of nodule boundaries 
than that provided by the detection system. 
These tools allow a user to apply different 
attenuation thresholds and interactively edit 
nodule boundaries (7). The edited segmentation 
results (ROIs) are stored in the Marking table 
as well as meta data relating to the radiologist 
who made the edits (in the Marking_Reviewer 
table). Following segmentation, diameters and/
or volumes are computed (see Equation [Section 
2.2]). These measurements are stored in the 
corresponding table shown in Figure 1.
The CAD architecture also includes capabilities 
for automatic tracking of a given nodule between 
serial CT exams. The tracking procedure uses 
nodule coordinates relative to anatomic landmarks 
(measured on the baseline scan) to automatically 
relocalize on subsequent scans (4).
2.3. Data mining and reporting
The data model described in Section 2.1 supports 
queries to retrieve serial nodule volumes from a 
given subject in a clinical trial. Given a subject ID, 
the Patient table can be queried to retrieve all CT 
image series associated with the subject, and then all 
nodule ROIs associated with the series. From each 
ROI, the system can compute volume and generate 
a b c
Figure 2. (a) Original CT image of the right lung. (b) Result of attenuation thresholding in the lung fi eld, with ROIs corresponding to blood 
vessels and pulmonary nodule in gray. (c) Automatically detected nodule (gray with arrow) following classifi cation step.
Figure 3. 3D rendering of a pulmonary nodule and blood vessels adjacent to the pleural surface.
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a report of the change in nodule volume between 
exams. The architecture supports web-based 
reporting of these results for a given patient. The 
report includes volumes and diameters, and applies 
World Health Organization (WHO) and Response 
Evaluation Criteria in Solid Tumors (RECIST) 
criteria (see Figure 4). The architecture also supports 
3D visualization of nodule changes (Figure 3).
The data model also supports more complex 
queries over larger populations (e.g. CAD perfor-
mance testing). To perform an analysis on all 
patients from a given clinical trial, a query can be 
performed on the table which associates experiments 
and image series through the primary keys of their 
respective tables (as described in Section 2.1). The 
ROIs from these images then can be retrieved as 
described above. In addition, a query can be applied 
to retrieve all nodule ROIs regardless of the associ-
ated experiment, effectively pooling subjects across 
trials. The would allow data mining to determine 
statistics regarding nodule growth rates (doubling 
times) based on data in the Measurements table.
2.4. CAD evaluation studies
To illustrate the architecture utilization, we describe 
two experimental trials aimed at evaluating CAD 
technology.
2.4.1. Computer-aided detection of lung 
nodules
The purpose of this preliminary study was to evaluate 
the accuracy of a CAD system in detecting lung 
nodules on CT exams and to assess its potential as a 
second reader. The details of the experimental design 
are provided in (6), but we outline them here.
This study involved 29 subjects from the data-
base who had undergone thin-section CT imaging 
for known or suspected lung nodules, as part of 
routine clinical practice. Images were acquired 
with a slice thickness and reconstruction interval 
≤ 1 mm. For each subject, the scan analyzed in this 
study had limited longitudinal coverage of around 
20 mm, giving 20–40 images per series.
Providing a gold standard for CAD evaluation, 
three experienced thoracic radiologists visually 
determined, by consensus review, the presence/
location of nodules on the 29 CT scans. Then, 14 
of the cases were used in CAD system development 
(as described in [6]); the remaining 15 cases used 
in the evaluation studies. The automated CAD 
system was run on these 15 cases and the sensitivity 
of nodule detection was measured along with the 
false positive rate (bronchovascular structures 
incorrectly marked as nodules). A thoracic radi-
ologist also read the cases under two reading 
conditions: 1) conventional un-assisted read and 
2) after CAD output was made available. The 
radiologist’s sensitivity for nodules pre- and post-
CAD assistance was measured.
2.4.2. Assessment of lung nodule size
The purpose of this study was to investigate the 
agreement between three techniques for quanti-
fying change in nodule size (7).
The study involved 15 subjects from the data-
base (not those used in the CAD evaluation). The 
subjects were undergoing therapy for metastatic 
lung cancer (colorectal, renal cell, or breast 
primary). Subjects were imaged with a thin-section 
CT protocol, with slice thickness ≤ 3 mm, at base-
Total Tumor Burden
Oct 30, 2001 Apr 30, 2002 Jun 17, 2002Scan Dates:
WHO Criteria
Sum Longest Diameter (mm):
Sum Bidimensional Product (mm2):
Changes from baseline (%):
Changes from baseline (%):
Changes from baseline (%):
Tumor Response:
43.1
390.0
4.029 6.909
623.1
45.6 55.0
753.2
8.236
+ 5.8
+ 59.8
+ 71.5 + 104.4
+ 93.1
+ 27.6
Tumor Response:
Tumor Response: Progressive Disease Progressive Disease
Progressive Disease Progressive Disease
Progressive Disease
Total Volume (cc):
RECIST Criteria
Stable Disease
Volumetrics
-
-
-
Figure 4. Report from CAD measurement system showing diameter and volume measurements and percentage changes from baseline. 
From these changes disease stability or progression is determined.
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line, and at two follow-up visits of 1–4 month 
intervals.
From the 15 subjects, a total of 32 lesions were 
selected for measurement. The three size measure-
ment techniques investigated were:
1. 1D longest diameter measurement made manu-
ally with electronic calipers on the axial image 
where the lesion appears largest;
2. 2D diameter measurements obtained using the 
longest diameter and the largest perpendicular 
diameter measured on the same axial image;
3. 3D volume measurement made by semi-auto-
mated segmentation of the nodule as described 
in Section 2.2 and volume computation using 
Equation (Section 2.2).
Following the WHO and RECIST criteria, the 1D 
and 2D measurements were used to categorize patients 
into four treatment response classifi cations: progres-
sive, stable, partial and complete. Volumetric criteria 
were used to classify response based on 3D measure-
ments. Response classifi cations were compared using 
the three measurement techniques.
3. Results
3.1. Computer-aided detection of lung 
nodules
The 15 subjects used to evaluate the CAD system had 
a total of 79 nodules (mean diameter: 3.34 mm), 57 
of which were micronodules <3 mm in diameter.
The CAD system automatically detected 78% 
of these nodules, with an average of 15 false posi-
tives per data set.
The radiologist independently (without CAD 
assistance) achieved a sensitivity of 62% with 0.3 
false positives per data set. When CAD was made 
available, the radiologist’s sensitivity increased to 
80% with no change in false positive rate. 
3.2. Assessment of lung nodule size
Thirty-two lesions from 15 patients were analyzed. 
Because each patient had a baseline and two 
follow-up scans, this yielded 30 response classifi -
cations for each measurement technique. The 1D 
and 3D measurements were concordant in 29 of 
30 classifi cations, while the 2D and 3D measure-
ments were concordant in 23 of 30 classifi cations. 
Level of agreement among the three methods was 
measured using a kappa statistic (K): 1D compared 
with 3D, K = 0.739 ± 0.345 (visits 1, 2) and 0.273 
± 0.323 (visits 2, 3); 2D compared with 3D, 
K = 0.655 ± 0.325 (visits 1, 2) and 0.200 ± 0.208 
(visits 2, 3). Agreement among the methods for 
round and ovoid nodules was also fair to poor.
3.3. Overall database size
The database currently stores data from 12 clinical 
trials and contains images received from a total of 
81 sites. The total number of patients in the data-
base is 3,017; the number of CT series is 24,959 
and the number of axial images is 3,051,693.
The majority of subjects are from clinical trials 
relating to lung cancer screening and diagnosis, 
and other smoking related-diseases (particularly 
emphysema). The largest trials and data mining 
queries have been in the area of emphysema treat-
ment (13); however, we expect to make similar 
large data mining queries for lung cancer.
4. Discussion
CAD and measurement systems have great poten-
tial to assist in nodule assessment as part of clinical 
trials. Other studies have since shown similar 
trends in terms of improving reader performance 
in nodule detection (2,14). In fact, these tools may 
be essential for the analysis of high-resolution CT 
images to be feasible on large cohorts of subjects. 
Manual segmentation and volume measurement of 
nodules would likely be too time-consuming for 
radiologists. CAD tools could enable large amounts 
of data to be extracted for mining.
CAD techniques are a subject of extensive 
research, and though sensitivities for nodules are 
improving, false positive rates remain unaccept-
ably high. The challenge in algorithm development 
is to reduce false positives while maintaining high 
sensitivity.
Although 1D and 2D tumor size measurement 
techniques are standard practice in clinical trials, 
the CAD tools described in this paper may enable 
volumetric measures to be made routinely. As 
described in Section 3.3, and in more detail in (7), 
preliminary results suggest that response rates 
based on volume may yield signifi cantly different 
outcomes to those from 1D and 2D methods. 
Volume may provide a more reproducible measure 
of nodule size, particularly for irregular lesions, 
but, if volume is to become the gold standard for 
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tumor size measurement, then volumetric response 
criteria will need to be defi ned.
The experiments presented demonstrate the 
ability to organize and mine CAD results within 
this architecture. In this case, mining is to evaluate 
the CAD technology itself; however, the mining 
could also involve more complex queries to 
advance our understanding of phenotypic signa-
tures of lung cancer or for therapeutic clinical trials. 
Though to date our lung cancer experiments have 
used only small numbers of cases from the data-
base, emphysema studies have used much larger 
numbers (13), and the infrastructure can handle it. 
Future lung cancer related experiments will use 
data from much larger cohorts.
The infrastructure currently incorporates QIWS 
and a research CAD system developed at UCLA. 
However, the data model can readily accommodate 
another CAD system and another DICOM-
compliant workstation with ROI display and 
editing capabilities. New components would 
require a data mediation layer to allow access to 
the database. For an alternative CAD system to be 
“plugged-in” it would need to be runnable as a 
stand-alone executable (i.e. not be tied to its own 
viewing workstation) so that it could be called from 
QIWS or another viewing workstation.
5. Conclusion
In this paper we have described a CAD system 
within an architecture to store and organize image 
and related data from large cohorts of subjects, 
acquired at multiple institutions. We have reported 
on CAD tools for extracting and storing lung 
nodule measurements and demonstrated their 
capabilities in two experimental studies.
CAD tools enable effi cient and reproducible 
analysis of large numbers of images. The architec-
ture has great potential for large cancer clinical 
trials involving imaging.
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